Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brand vs Generic Tacrolimus in Kidney Transplant Recipients
NCT02866682Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Mar 2018
- Primary completion
- Jun 2021
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by University of California, Los Angeles. Started Mar 2018; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02866682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866682.